ClinConnect ClinConnect Logo
Search / Trial NCT04690049

Therapeutic Progressive Exercise on Shoulder Impingement Syndrome

Launched by UNIVERSITY OF MALAGA · Dec 25, 2020

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Shoulder Impingement Syndrome Tendinopathy Exercise

ClinConnect Summary

This clinical trial is studying a new exercise program designed to help people with shoulder impingement syndrome, a common condition that causes pain and discomfort in the shoulder area. The goal is to understand the best way to progress through different exercises to help improve strength and reduce pain for those affected. The trial is not yet recruiting participants, but it aims to include adults over the age of 18 who have been diagnosed with shoulder impingement syndrome and show specific signs of the condition.

To participate in the trial, individuals must meet certain criteria, such as having a previous diagnosis of shoulder impingement syndrome and experiencing specific painful symptoms. However, those with other shoulder or neck issues, certain medical conditions, or who are currently taking specific medications may not be eligible. Participants can expect to follow a structured exercise program, which may help improve their shoulder function and reduce pain. This study could pave the way for better treatments for this common condition.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Subjects older than 18 years.
  • Subjects previously diagnosed with shoulder impingement syndrome.
  • Presence of 3 of the following sings: impingement sign according to Neer and to Hawking-Kennedy, positive result on Jobes test, painful arc, and positive result on Patte's manoeuvre.
  • Exclusion Criteria:
  • Findings of spinal radiculopathy.
  • General neck and shoulder pain.
  • Symptoms of frozen shoulder.
  • Pregnancy.
  • Fybromyalgia.
  • Suspected polyarthritis.
  • Chronic pain syndrome.
  • Altered blood coagulation.
  • Consumption of anticoagulants, opioids or antiepileptics.
  • Drug intakes.
  • Alcohol intakes higher than 27.4 grams for men or 13.7 grams for women.
  • Allergies.
  • Cancer.

About University Of Malaga

The University of Malaga, a leading academic institution in Spain, is committed to advancing medical research and improving patient outcomes through innovative clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive resources and expertise in various fields, including medicine, health sciences, and biotechnology, to conduct rigorous studies. The institution is dedicated to fostering a culture of ethical research practices and ensuring the highest standards of safety and efficacy in its clinical trials, ultimately contributing to the development of groundbreaking therapies and enhancing the overall quality of healthcare.

Locations

Patients applied

0 patients applied

Trial Officials

Antonio Cuesta-Vargas, PhD

Study Chair

University of Malaga

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials